FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LIN, Z.
Right arrow Articles by UHL, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LIN, Z.
Right arrow Articles by UHL, G. R.
(The FASEB Journal. 2000;14:715-728.)
© 2000 FASEB

Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression

ZHICHENG LIN*, MASANARI ITOKAWA* and GEORGE R. UHL*,{dagger}1

* Molecular Neurobiology Branch, NIDA-IRP, National Institutes of Health, and
{dagger} Departments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA

1Correspondence: Molecular Neurobiology Branch, NIDA-IRP, National Institutes of Health, 5500 Nathan Shock Dr., Baltmore, MD 21224, USA.

Analyses of mutation effects can aid in understanding how large proteins act. The dopamine transporter (DAT) mediates complex actions in recognizing cocaine and in recognizing and translocating dopamine, sodium, and chloride. DAT proline residues, especially those in transmembrane (TM) domains, are good candidates for involvement in these DAT actions. We now report production of mutants substituting alanine and/or glycine residues for 16 prolines located in or near putative DAT TM domains. We examine effects of these modifications on DAT expression, dopamine uptake, and cocaine analog binding. Mutants in prolines located in five DAT TM domains and four connecting loops alter apparent DAT membrane targeting. Five mutations decrease dopamine affinities more than threefold without significantly decreasing cocaine analog affinities. One decreases cocaine analog affinity without decreasing dopamine affinity. Two mutations decrease affinities for both dopamine and cocaine analog. P101 is especially implicated in dopamine uptake. Alanine substitution for this proline yields dopamine Vmax values of less than 3% of wild-type values despite dopamine affinities more than fourfold higher than wild-type and normal Na+ and Cl- dependence. These DAT proline mutants identify DAT regions likely for dopamine translocation and for recognition of dopamine and cocaine.—Lin, Z., Itokawa, M., Uhl, G. R. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.


Key Words: affinity • translocation • ion gradients • turnover rate • plasma membrane targeting




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Hussainzada, A. Khandewal, and P. W. Swaan
Conformational Flexibility of Helix VI Is Essential for Substrate Permeation of the Human Apical Sodium-Dependent Bile Acid Transporter
Mol. Pharmacol., February 1, 2008; 73(2): 305 - 313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Kinclova-Zimmermannova, M. Zavrel, and H. Sychrova
Identification of Conserved Prolyl Residue Important for Transport Activity and the Substrate Specificity Range of Yeast Plasma Membrane Na+/H+ Antiporters
J. Biol. Chem., August 26, 2005; 280(34): 30638 - 30647.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
R. E. Martin and K. Kirk
The Malaria Parasite's Chloroquine Resistance Transporter is a Member of the Drug/Metabolite Transporter Superfamily
Mol. Biol. Evol., October 1, 2004; 21(10): 1938 - 1949.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Koike, G. Conseil, E. M. Leslie, R. G. Deeley, and S. P. C. Cole
Identification of Proline Residues in the Core Cytoplasmic and Transmembrane Regions of Multidrug Resistance Protein 1 (MRP1/ABCC1) Important for Transport Function, Substrate Specificity, and Nucleotide Interactions
J. Biol. Chem., March 26, 2004; 279(13): 12325 - 12336.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. D. Gaffaney and R. A. Vaughan
Uptake Inhibitors but not Substrates Induce Protease Resistance in Extracellular Loop Two of the Dopamine Transporter
Mol. Pharmacol., March 1, 2004; 65(3): 692 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Loland, C. Granas, J. A. Javitch, and U. Gether
Identification of Intracellular Residues in the Dopamine Transporter Critical for Regulation of Transporter Conformation and Cocaine Binding
J. Biol. Chem., January 30, 2004; 279(5): 3228 - 3238.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. K. Henry, E. M. Adkins, Q. Han, and R. D. Blakely
Serotonin and Cocaine-sensitive Inactivation of Human Serotonin Transporters by Methanethiosulfonates Targeted to Transmembrane Domain I
J. Biol. Chem., September 26, 2003; 278(39): 37052 - 37063.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Lin, P.-W. Zhang, X. Zhu, J.-M. Melgari, R. Huff, R. L. Spieldoch, and G. R. Uhl
Phosphatidylinositol 3-Kinase, Protein Kinase C, and MEK1/2 Kinase Regulation of Dopamine Transporters (DAT) Require N-terminal DAT Phosphoacceptor Sites
J. Biol. Chem., May 23, 2003; 278(22): 20162 - 20170.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. Wu and H. H. Gu
Cocaine Affinity Decreased by Mutations of Aromatic Residue Phenylalanine 105 in the Transmembrane Domain 2 of Dopamine Transporter
Mol. Pharmacol., March 1, 2003; 63(3): 653 - 658.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Lin and G. R. Uhl
Dopamine Transporter Mutants with Cocaine Resistance and Normal Dopamine Uptake Provide Targets for Cocaine Antagonism
Mol. Pharmacol., April 1, 2002; 61(4): 885 - 891.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Vaughan, J. D. Gaffaney, J. R. Lever, M. E. A. Reith, and A. K. Dutta
Dual Incorporation of Photoaffinity Ligands on Dopamine Transporters Implicates Proximity of Labeled Domains
Mol. Pharmacol., April 16, 2001; 59(5): 1157 - 1164.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
Z. Lin, W. Wang, and G. R. Uhl
Dopamine Transporter Tryptophan Mutants Highlight Candidate Dopamine- and Cocaine-Selective Domains
Mol. Pharmacol., April 13, 2001; 58(6): 1581 - 1592.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. G. F. Rasmussen, F. I. Carroll, M. J. Maresch, A. D. Jensen, C. G. Tate, and U. Gether
Biophysical Characterization of the Cocaine Binding Pocket in the Serotonin Transporter Using a Fluorescent Cocaine Analogue as a Molecular Reporter
J. Biol. Chem., February 9, 2001; 276(7): 4717 - 4723.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Kamdar, K. M. Y. Penado, G. Rudnick, and M. M. Stephan
Functional Role of Critical Stripe Residues in Transmembrane Span 7 of the Serotonin Transporter. EFFECTS OF Na+, Li+, AND METHANETHIOSULFONATE REAGENTS
J. Biol. Chem., February 2, 2001; 276(6): 4038 - 4045.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by The Federation of American Societies for Experimental Biology.